Bibliographic information
GuidelineWHO consolidated guidelines on drug-resistant tuberculosis treatment
Year of Publication2019
Issuing InstitutionWorld Health Organization
Recommendation
New
Antiretroviral therapy is recommended for all patients with HIV and drug-resistant TB requiring second line antituberculosis drugs, irrespective of CD4 cell count, as early as possible (within the first 8 weeks) following initiation of antituberculosis treatment
Recommended in favor
Strong
Certainty of evidence
Very low